Showing 1561-1570 of 10578 results for "".
Medical Costs Skyrocket and New York Times Reporter Finds a Scapegoat
https://practicaldermatology.com/topics/practice-management/medical-costs-skyrocket-and-emnew-york-timesem-reporter-finds-a-scapegoat/21404/Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/Education is Key to Preventing Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/education-is-key-to-preventing-skin-cancers/22938/James A. Solomon, MD, PhD
https://practicaldermatology.com/topics/general-topics/james-a-solomon-md-phd/21559/Dermatology: A Specialty Poised for Growth
https://practicaldermatology.com/topics/general-topics/editorial-board/21649/BUSINESS ADVISOR: The Just-in-Time Model: Smart Inventory Management in Tough Economic Times
https://practicaldermatology.com/topics/general-topics/the-just-in-time-model-smart-inventory-management-in-tough-economic-times/21963/Meeting inventory challenges can help control costs and ensure consistent cash flow during economic difficulties.Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/21025/Financial Focus for Young Physicians
https://practicaldermatology.com/topics/practice-management/financial-focus-for-young-physicians-first-build-your-foundation/21416/Two important steps young dermatologists should take now for future financial security.How to Protect Against Malpractice Liability
https://practicaldermatology.com/topics/practice-management/strategies-to-protect-against-malpractice-liability/20546/Take proper steps to protect yourself.DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.